City

San Francisco (2)

Celje (1)

Izola (1)

Ljubljana (1)

Maribor (1)

Overall Status

Not yet recruiting (2)

Recruiting (1)

Phase

phase 1/phase 2 (2)

Sponsor

University of California, San Francisco (2)

University of Ljubljana (1)

Collaborator

General Hospital Izola (1)

General and Teaching Hospital Celje (1)

Novartis (1)

United States Department of Defense (1)

University Medical Centre Ljubljana (1)

University Medical Centre Maribor (1)

Intervention

clemastine fumarate (2)

placebo (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

multiple sclerosis brain lesion

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine

Not yet recruiting

Demyelinating Diseases
+4 more

Clemastine Fumarate
Placebo

San Francisco, California

Sandler Neurosciences Building, Neurological Clinical Research U

Oct 3, 2023

Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

Not yet recruiting

Multiple Sclerosis (MS)
+6 more

Clemastine Fumarate
Placebo

San Francisco, California

Sandler Neurosciences Building, Neurological Clinical Research U

Jan 23, 2023

Multiple Sclerosis Study

Recruiting

Multiple Sclerosis
+2 more

Ljubljana, Osrednjeslovenska, Slovenia
+3 more

Jun 16, 2022